Back to Research Hub
Tekla Life Sciences Investors
HQL
$16.78+0.11 (+0.66%)
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe.
StreetsValue research for Tekla Life Sciences Investors (HQL)
Members get the full report for Tekla Life Sciences Investors: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.